|
Medication
Dosing
The medications used in the treatment of
opioid addiction (methadone, LAAM [levo-alpha-acetyl-methadol],
and buprenorphine are those that are FDA
approved) are used to stabilize clients,
block euphoria, and eliminate withdrawal
and craving. The initial dose of methadone
should not exceed 30 mg of methadone and
is individually determined by a physician
following the history and physical examination.
Dosing protocols are individualized.
|
|
|
Take-Home
Medication
The
Medical Director, with input from members
of the clinical team, determines if a person
is eligible for unsupervised take-home medications
based on specified criteria and length of
time in the program.
|
| |
|
Medically Supervised Withdrawal (MSW)
Medically Supervised Withdrawal (MSW) is the term used for detoxification from methadone, since methadone itself should not be considered a toxic substance. This procedure is designed to eliminate the withdrawal syndrome. MSW may occur for a variety of reasons, and it should be physician-directed, be documented appropriately, and include supportive services and/or referral if necessary.
|
|